Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Announces Positive Results From Phase III Champ Study Of NVK002

Oct 28 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * POSITIVE RESULTS FROM PHASE III CHAMP STUDY OF NVK002 FOR
TREATMENT OF MYOPIA PROGRESSION IN CHILDREN

Source text for Eikon:  ID:nHKS4vQTlD 
Further company coverage:  6622.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news